The trademark application THE DPX PLATFORM was filed by ImmunoVaccine Technologies Inc., a corporation established under the laws of Canada (the "Applicant"). The application was published for oppositions on May 1, 2022, and it was registered by office on August 8, 2022 without any oppositions.
The application was filed in Swedish (English was selected as the second language).
Change of name and professional address of the trademark registration was recorded on February 15, 2023.
Goods And Services
The mark was filed in class 5 with Drug delivery technology in the form of lipid vesicles, that can be formulated with a wide variety of bioactive molecules and results in a specific immune response.
The mark was filed in class 42 with following description of goods:
Pharmaceutical research and development
Laboratory research in the fields of chemistry and biochemistry
Research in the field of pharmaceutical drug delivery
Medical research
Providing medical and scientific research information in the field of pharmaceuticals and clinical trials
Hosting websites with information in the field of pharmaceutical research and development.